Home/Filings/4/0001209191-17-052501
4//SEC Filing

Shames Richard S. 4

Accession 0001209191-17-052501

CIK 0001377121other

Filed

Sep 11, 8:00 PM ET

Accepted

Sep 12, 7:50 PM ET

Size

5.6 KB

Accession

0001209191-17-052501

Insider Transaction Report

Form 4
Period: 2017-09-12
Shame Richard S
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2017-09-12$14.31/sh3,687$52,7530 total
Footnotes (3)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 9, 2017.
  • [F2]Includes 1,822 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on September 8, 2017.
  • [F3]The shares were sold at prices ranging from $14.251 to $14.3443. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Issuer

Protagonist Therapeutics, Inc

CIK 0001377121

Entity typeother

Related Parties

1
  • filerCIK 0001675878

Filing Metadata

Form type
4
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 7:50 PM ET
Size
5.6 KB